PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.29%
Negative revenue growth while RUN stands at 12.90%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
2.22%
Positive gross profit growth while RUN is negative. John Neff would see a clear operational edge over the competitor.
12.60%
EBIT growth 50-75% of RUN's 23.91%. Martin Whitman would suspect suboptimal resource allocation.
9.04%
Operating income growth above 1.5x RUN's 0.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
10.29%
Net income growth under 50% of RUN's 460.66%. Michael Burry would suspect the firm is falling well behind a key competitor.
20.24%
EPS growth under 50% of RUN's 456.14%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
20.24%
Diluted EPS growth under 50% of RUN's 436.85%. Michael Burry would worry about an eroding competitive position or excessive dilution.
14.39%
Share count expansion well above RUN's 1.22%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
14.39%
Diluted share count expanding well above RUN's 1.26%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-202.05%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-292.59%
Negative FCF growth while RUN is at 156.78%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
39.48%
10Y revenue/share CAGR under 50% of RUN's 231.43%. Michael Burry would suspect a lasting competitive disadvantage.
128.96%
5Y revenue/share CAGR above 1.5x RUN's 64.82%. David Dodd would look for consistent product or market expansions fueling outperformance.
73.16%
Positive 3Y CAGR while RUN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
75.96%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
-822.78%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-92.68%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
67.76%
Below 50% of RUN's 1473.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-4064.44%
Negative 5Y net income/share CAGR while RUN is 1185.12%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-466.76%
Negative 3Y CAGR while RUN is 220.80%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
29.34%
Below 50% of RUN's 72.95%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-16.57%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.84%
AR growth well above RUN's 8.37%. Michael Burry fears inflated revenue or higher default risk in the near future.
15.80%
Inventory growth well above RUN's 18.52%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-1.87%
Negative asset growth while RUN invests at 4.18%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.65%
We have a declining book value while RUN shows 11.80%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-28.87%
We’re deleveraging while RUN stands at 3.38%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
39.51%
We increase R&D while RUN cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-0.21%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.